Skip to main content
Protagonist Therapeutics, Inc. (PTGX)
NASDAQ: PTGX · Real-Time Price · USD
46.46
+4.81 (11.55%)
At close: Nov 22, 2024, 4:00 PM
45.93
-0.53 (-1.14%)
After-hours: Nov 22, 2024, 5:35 PM EST

Protagonist Therapeutics Revenue

Protagonist Therapeutics had revenue of $4.68M in the quarter ending September 30, 2024. This brings the company's revenue in the last twelve months to $323.80M. In the year 2023, Protagonist Therapeutics had annual revenue of $60.00M with 125.73% growth.

Revenue (ttm)
$323.80M
Revenue Growth
+125.73%
P/S Ratio
8.77
Revenue / Employee
$2,891,027
Employees
112
Market Cap
2.77B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202360.00M33.42M125.73%
Dec 31, 202226.58M-776.00K-2.84%
Dec 31, 202127.36M-1.27M-4.44%
Dec 31, 202028.63M28.40M12,293.07%
Dec 31, 2019231.00K-30.69M-99.25%
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Privia Health Group 1.72B
Catalyst Pharmaceuticals 460.48M
Twist Bioscience 312.97M
Iovance Biotherapeutics 90.86M
Geron 29.48M
Janux Therapeutics 13.05M
Centessa Pharmaceuticals 6.85M
Revenue Rankings

PTGX News

More News